Antibiotics Market to hit $40.78 Billion by 2025 – Global Insights on Top Trends, Growth Drivers, Competitive Landscape, Regulatory Scenario and Business Opportunities: Adroit Market Research
/
Date19 Jan 2020
Email Print Friendly Share Dallas, Texas, Jan. 18, 2020 (GLOBE NEWSWIRE) — The “Global Antibiotics Market Size 2018, By Drug Class (Broad spectrum penicillins, Cephalosporins,... Read More →
ORHub, Inc. – Digital Health Innovator Secures Another Customer
/
Date18 Jan 2020
Email Print Friendly Share LAGUNA BEACH, Calif., Jan. 17, 2020 (GLOBE NEWSWIRE) — via NetworkWire – ORHub, Inc. (OTC: ORHB; the “Company”), a Microsoft Silver... Read More →
Global Diphtheria, Pertussis, and Tetanus (DTaP) Vaccine Market is Expected to Reach USD 5.07 Billion by 2026 : Fior Markets
/
Date17 Jan 2020
Email Print Friendly Share New Jersey, NJ, Jan. 16, 2020 (GLOBE NEWSWIRE) — As per the report published by Fior Markets, the global diphtheria, pertussis, and... Read More →
Life Chiropractic College West uses biomarkers to support Vitalistic research
/
Date16 Jan 2020
Email Print Friendly Share San Francisco Bay Area, California, Jan. 15, 2020 (GLOBE NEWSWIRE) — How do we know – with irrefutable research and hard... Read More →
Ultrasound Market To Reach USD 10.44 Billion By 2027 | Reports And Data
/
Date15 Jan 2020
Email Print Friendly Share New York, Jan. 14, 2020 (GLOBE NEWSWIRE) — The global Ultrasound Market is forecasted to reach USD 10.44 Billion by 2027,... Read More →
Dr. LaKesha Legree of Elev8 MD Wellness Center Launches Mental Health Awareness Campaign featuring William Bryant, Jr. of OWN’s Queen Sugar to Mark Its First Anniversary
/
Date14 Jan 2020
Email Print Friendly Share CHARLOTTE, N.C., Jan. 13, 2020 (GLOBE NEWSWIRE) — Celebrating its first successful year in treating patients, Elev8 MD Wellness Center, Charlotte’s... Read More →
Adverum Biotechnologies Reports Continued Momentum with OPTIC Trial for ADVM-022 Intravitreal Gene Therapy in Wet AMD and Provides 2020 Outlook
/
Date13 Jan 2020
Email Print Friendly Share — OPTIC phase 1 trial progressing with plans to complete patient dosing in cohort three, begin enrollment in cohort four in... Read More →
Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the Atlantic Coast Retina Club Macula 20/20 Annual Meeting
/
Date12 Jan 2020
Email Print Friendly Share –44 week median follow up for patients (n=6)––Zero anti-VEGF rescue injections required following intravitreal ADVM-022; First patient has reached 52-weeks post... Read More →
Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
/
Date11 Jan 2020
Email Print Friendly Share LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused... Read More →
AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD, in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency, at Biotech Showcase 2020 Conference (January 13) in San Francisco
/
Date10 Jan 2020
Email Print Friendly Share Initial data from the first five patients indicate positive trends for all primary and secondary safety and efficacy endpoints in AzurRx’s... Read More →